业绩披露 每经记者｜陈晴 每经编辑｜文多 博济医药：控股股东及其一致行动人拟减持不超公司3%的股份 博济医药公告，控股股东王廷春及一致行动人拟于2025年9月12日至2025年12月11日，通过大宗交易或 集中竞价合计减持不超过1148.65万股公司股份，即不超过公司总股本的3.00%。 吉视传媒：上半年净亏损2.32亿元 吉视传媒公告，2025年上半年营业收入为9.97亿元，同比增长8.70%，归母净利润为亏损2.32亿元，上 年同期公司净亏损1.95亿元。 中国石化：上半年归母净利润为214.83亿元 中国石化公告，2025年上半年营业收入为1.41万亿元，同比下降10.6%，归母净利润为214.83亿元，同 比下降39.8%。 宝丰能源：上半年归母净利润同比增长73.02% 宝丰能源公告，2025年上半年营业收入为228.20亿元，同比增长35.05%，归母净利润为57.18亿元，同 比增长73.02%。 增减持 中银证券：江西铜业拟减持不超公司3%的股份 中银证券公告，截至公告披露日，股东江西铜业持有公司1.3亿股，占公司总股本的4.70%；因自身经营 发展需要，拟合计减持不超过8334万股，即不超公 ...

博济医药公告，持有公司股份118674370股（占公司剔除回购专用证券账户中股份数量后的总股本比例 30.99%）的控股股东、实际控制人王廷春及持有公司股份5536700股（占公司剔除回购专用证券账户中 股份数量后的总股本比例1.45%）的一致行动人横琴广金美好基金管理有限公司－广金美好费米十三号 私募证券投资基金，计划在本公告披露之日起15个交易日后的3个月内，以大宗交易或集中竞价的方式 合计减持本公司股份不超过11486500股（占公司剔除回购专用证券账户中股份数量后的总股本比例的 3.00%）。 (本文来自第一财经) ...

人民财讯8月21日电，博济医药（300404）8月21日晚间公告，控股股东、实际控制人王廷春及其一致行 动人横琴广金美好基金管理有限公司-广金美好费米十三号私募证券投资基金(简称"费米十三号")计划15 个交易日后的3个月内，以大宗交易或集中竞价的方式合计减持公司股份不超过1148.65万股(占公司剔 除回购专用证券账户中股份数量后的总股本比例的3.00%)。 ...

博济医药公告，控股股东王廷春及一致行动人费米十三号拟于2025年9月12日至2025年12月11日，通过 大宗交易或集中竞价合计减持不超过1148.65万股，比例3.00%。其中，费米十三号拟大宗交易减持 170.79万股、集中竞价减持382.88万股，王廷春拟大宗交易减持594.98万股。 ...

证券代码：300404 证券简称：博济医药 公告编号：2025-062 博济医药科技股份有限公司 关于控股股东及其一致行动人减持股份预披露公告 公司控股股东王廷春先生及其一致行动人横琴广金美好基金管理有限公司 －广金美好费米十三号私募证券投资基金保证向本公司提供的信息内容真实、准 确、完整，没有虚假记载、误导性陈述或重大遗漏。 本公司及董事会全体成员保证公告内容与信息披露义务人提供的信息一致。 特别提示： 持有博济医药科技股份有限公司（以下简称"公司"）股份 118,674,370 股 （占公司剔除回购专用证券账户中股份数量后的总股本比例 30.99%）的控股股 东、实际控制人王廷春先生及持有公司股份 5,536,700 股（占公司剔除回购专用 证券账户中股份数量后的总股本比例 1.45%）的一致行动人横琴广金美好基金管 理有限公司－广金美好费米十三号私募证券投资基金（以下简称"费米十三 号"）计划在本公告披露之日起 15 个交易日后的 3 个月内，以大宗交易或集中 竞价的方式合计减持本公司股份不超过 11,486,500 股（占公司剔除回购专用证券 账户中股份数量后的总股本比例的 3.00%）。 公司于近日 ...

Group 1 - The healthcare services sector has experienced a short-term decline, with Boji Pharmaceutical falling over 6% [1] - Other companies such as Nanmo Biology, Zhaoyan New Drug, Ruizhi Pharmaceutical, and Sanbo Brain Science also saw declines [1]

Core Viewpoint - The A-share market shows a slight decline with the Shanghai Composite Index closing at 3727.29 points, just above the five-day moving average, indicating a stable market trend despite a minor drop of 0.02% [1] Group 1: Market Overview - The total trading volume of A-shares reached 26,406.80 billion yuan today [1] - A total of 740 A-shares have surpassed the five-day moving average, reflecting a positive market sentiment [1] Group 2: Individual Stock Performance - Stocks with significant deviation from the five-day moving average include: - Boji Pharmaceutical (博济医药) with a deviation rate of 15.25% and a daily increase of 19.98% [2] - Nongshang Environment (农尚环境) with a deviation rate of 14.42% and a daily increase of 20.02% [2] - Tongyuan Environment (通源环境) with a deviation rate of 13.12% and a daily increase of 17.86% [2] - Other notable stocks with smaller deviation rates include: - Guodian Nari (国电南瑞) and Huatu Shanding (华图山鼎), which have just crossed the five-day moving average [1]

序号代码名称最新价涨跌幅主力净流入主力净占比1300404博济医药13.1519.981.60亿元25.81%2002044 美年健康5.621.631.21亿元12.18%3688222成都先导22.79-1.044455.81万元8.21%4002172澳洋健康 4.292.884286.71万元16.8%5603108润达医疗18.30.272967.82万元5.33%6300149睿智医药13.722.162281.96 万元2.17%7688246嘉和美康36.840.331193.96万元9.05%8000516国际医学5.440.181115.57万元 5.19%9600327大东方5.031.41936.31万元6.39%10301033迈普医学85.68-1.29623.31万元5.72% 8月19日，医疗服务行业下跌0.43%，今日主力资金流出36.14亿元，成分股13只上涨，29只下跌。 主力资金净流出居前的分别为药明康德（25.63亿元）、创新医疗（5.56亿元）、康龙化成（1.51亿 元）、昭衍新药（1.49亿元）、爱尔眼科（1.44亿元）。 来源：金融界 ...

Market Overview - The three major A-share indices collectively declined on the 19th, with the Shanghai Composite Index down 0.02%, the Shenzhen Component Index down 0.12%, and the ChiNext Index down 0.17% [2] - The North Securities 50 Index increased by 1.27% [2] - The total trading volume in the Shanghai and Shenzhen markets was 26,407 billion yuan, a decrease of 1,685 billion yuan compared to the previous day [2] Stock Performance - Over 2,900 stocks in the market experienced an increase [2] - The liquor sector continued to strengthen, with stocks like JiuGuiJiu hitting the daily limit and SheDe Liquor rising over 6% [2] - The innovative drug sector saw a peak and then a pullback, with stocks such as ShenLian Bio and BoJi Medicine hitting the daily limit [2] - Huawei HiSilicon concept stocks showed strong fluctuations, with ChengMai Technology hitting the daily limit and Sichuan Changhong also reaching the daily limit [2] Sector Adjustments - The insurance sector experienced a pullback, with China Life and China Pacific Insurance both declining over 2% [2] - The military equipment sector also faced adjustments, with stocks like FeiLiHua and GuangQi Technology dropping over 6% [2]

Market Overview - As of August 19, A-shares saw all three major indices rise collectively, with the Shanghai Composite Index up by 0.30%, the Shenzhen Component Index up by 0.30%, and the ChiNext Index up by 0.39% [2] - The North Star 50 Index experienced a significant increase of 3.16% [2] - The total trading volume in the Shanghai and Shenzhen markets reached 16,781 billion yuan, a decrease of 686 billion yuan compared to the previous day [2] Stock Performance - Over 3,200 stocks in the market recorded gains [2] - The liquor sector continued to perform strongly, with stocks like JiuGuiJiu hitting the daily limit and SheDe Liquor rising over 7% [2] - The innovative drug sector also showed strength, with companies such as ShenLian Bio and BoJi Pharma hitting the daily limit, and several others like SaiLi Medical and JiMin Health also reaching the daily limit [2] - Huawei HiSilicon concept stocks experienced fluctuations but generally trended upwards, with ChengMai Technology and Sichuan ChangHong both hitting the daily limit [2] Sector Adjustments - The insurance sector faced adjustments, with China Life Insurance dropping over 1% [2] - The military equipment sector also saw declines, with FengHuo Electronics and GuangQi Technology both falling over 5% [2]